HomeFileCoronary disease

Coronary disease

CTO: Trials vs. Real-World

Percutaneous coronary intervention of chronic total occlusions (CTO) is currently indicated for symptom improvement, as studies have...

SOLACI-SOCIME 2022 | The future of the innovation in cardiovascular interventions – Dr. Chaim Lotan

Enjoy this master conference given by Dr. Chaim Lotan during the SOLACI-SOCIME 2022 Congress held at Expo...

SOLACI-SOCIME 2022 | Treatment Consideration in Women: Results from the RECOVER III Study – By Dr. Alexandra Lansky

Disfrute esta conferencia magistral brindada por la Dra. Alexandra Lansky durante el Congreso SOLACI-SOCIME 2022 realizado en...

Longitudinal Deformation of a Stent with the POT Technique

The fractal geometry of coronary bifurcations offers a mismatch between the proximal diameter of the main branch...

Coronary Physiology Is Useful in Chronic Kidney Disease

Coronary physiology, FFR and iFR, has been shown safe to defer lesions and effective to save stents...

Progress-CTO Score: A Key New Tool to Plan CTO

Intervention of chronic total occlusions (CTO) through angioplasty (PCI) can cause complications, even in highly experienced centers. Plenty...

Changes in Coronary Collateral Function Post CTO Intervention

In the last few years, we have seen significant growth of chronic total occlusion (CTO) percutaneous intervention,...

Thin vs. Ultrathin Stents: 1-Year Clinical Results After IVUS/OCT-Guided Implantation

Second generation drug-eluting stents have lower frequency of thrombotic complications and in-stent restenosis. While clinical results have...